Day: September 18, 2025

This will be the last reverse stock split Bollinger initiates for the next three years BREA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — via IBN – Bollinger Innovations, Inc. (NASDAQ: BINI) (“Bollinger Innovations” or the “Company”), an electric vehicle manufacturer, today announces that it will effect a 1-for-250 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on Sept. 22, 2025, at 12:01 a.m. Eastern Time. The Common Stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the existing BINI symbol and will begin trading on a split-adjusted basis when the market opens on Sept. 22, 2025. The new CUSIP number for the Common Stock following the Reverse Stock Split will be 62526P877. This will be the last reverse stock split Bollinger...

MONTREAL, Sept. 18, 2025 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) announced today that Glenn J. Chamandy, President & Chief Executive Officer, Luca Barile, Executive Vice-President, Chief Financial Officer and Jessy Hayem, Senior Vice-President, Head of Investor Relations and Global Communications will participate in a fireside chat and one-on-one meetings with investors at the 24th Annual CIBC Eastern Institutional Investor Conference in Montreal on Thursday, September 25, 2025. About GildanGildan is a leading manufacturer of everyday basic apparel. The Company’s product offering includes activewear, underwear, and socks, sold to a broad range of customers, including wholesale distributors, screenprinters or embellishers, as well as to retailers that sell to consumers through their physical stores and/or...

Aspo Plc Stock exchange release 18 September 2025 at 15.00 EEST Aspo provides restated financial information for 2024 and the first half of 2025 to reflect the divestment of Leipurin Aspo announced in August 2025 the divestment of Leipurin business to Lantmännen. The transaction is subject to regulatory approvals and is expected to be completed in the first quarter of 2026. The divestment will lead to changes in Aspo’s reporting structure. Leipurin has previously formed one of Aspo Group’s reportable segments. As a result of the signed divestment agreement, Leipurin will be presented as a discontinued operation as of the third quarter of 2025. Aspo’s continuing operations will include the figures for ESL Shipping, Telko and other operations. Aspo’s financial information for 2024 and the first two quarters of 2025 has been restated...

LOWELL, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) — MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, invites attendees of European Microwave Week (EuMW) 2025 in Utrecht, Netherlands to visit Booth #D068 from September 23 to 25, 2025 and review its broad portfolio of RF, microwave and millimeter wave (mmWave) product solutions, and foundry services. MACOM will exhibit a variety of demonstrations that highlight its expanding product capabilities for space, radar, RF-over-Fiber (RFoF) and high reliability applications. Attendees will have the opportunity to engage with MACOM’s technical experts and explore how its technologies support next-generation performance across commercial and aerospace markets. EuMW 2025 demonstrations will include: SATCOM Applications:Ka-Band Power Amplifier (PA) and...

TORONTO, Sept. 18, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, announces that Health Canada has granted a Product License (PN 80144141) for its natural health product, Qlarity. Quantum licensed a similar product, as a dietary supplement, for sale in the United States under the brand name unbuzzd™ (unbuzzd.com). This Product License from Health Canada permits Quantum to sell Qlarity in Canada. Health Canada’s product license permits the following recommended uses...